6080-58-6O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]HXGWMCJZLNWEBC-UHFFFAOYSA-KLithium Citrate can cause developmental toxicity according to state or federal government labeling requirements.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (41.5%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 65 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwendenalpha-glucosidase inhibitor, antidiabetic
DefinitionChEBI: A hydrate that is the tetrahydrate form of lithium citrate. It is used as a source of lithium for the treatment of anxiety disorders, bipolar disorder, and depression.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
6080-58-6DTXSID00976276CHEMBL2103738CHEBI:64754